Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 2
1966 1
1967 6
1968 3
1969 4
1970 1
1972 2
1974 2
1975 1
1976 3
1977 5
1978 5
1979 1
1981 2
1982 1
1984 1
1985 1
1986 1
1987 1
1988 2
1989 4
1990 4
1991 5
1992 9
1993 10
1994 10
1995 9
1996 19
1997 10
1998 8
1999 13
2000 11
2001 15
2002 11
2003 16
2004 12
2005 13
2006 16
2007 23
2008 12
2009 14
2010 17
2011 19
2012 20
2013 25
2014 23
2015 51
2016 45
2017 41
2018 54
2019 56
2020 76
2021 36
Text availability
Article attribute
Article type
Publication date

Search Results

702 results
Results by year
Filters applied: . Clear all
Page 1
Myth or Reality-Transdermal Magnesium?
Gröber U, Werner T, Vormann J, Kisters K. Gröber U, et al. Among authors: werner t. Nutrients. 2017 Jul 28;9(8):813. doi: 10.3390/nu9080813. Nutrients. 2017. PMID: 28788060 Free PMC article. Review.
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
Coleman RL, Fleming GF, Brady MF, Swisher EM, Steffensen KD, Friedlander M, Okamoto A, Moore KN, Efrat Ben-Baruch N, Werner TL, Cloven NG, Oaknin A, DiSilvestro PA, Morgan MA, Nam JH, Leath CA 3rd, Nicum S, Hagemann AR, Littell RD, Cella D, Baron-Hay S, Garcia-Donas J, Mizuno M, Bell-McGuinn K, Sullivan DM, Bach BA, Bhattacharya S, Ratajczak CK, Ansell PJ, Dinh MH, Aghajanian C, Bookman MA. Coleman RL, et al. Among authors: werner tl. N Engl J Med. 2019 Dec 19;381(25):2403-2415. doi: 10.1056/NEJMoa1909707. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562800 Free PMC article. Clinical Trial.
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, Berek JS, Chen LM, Cristea M, DeRosa M, ElNaggar AC, Gershenson DM, Gray HJ, Hakam A, Jain A, Johnston C, Leath CA III, Liu J, Mahdi H, Matei D, McHale M, McLean K, O'Malley DM, Penson RT, Percac-Lima S, Ratner E, Remmenga SW, Sabbatini P, Werner TL, Zsiros E, Burns JL, Engh AM. Armstrong DK, et al. Among authors: werner tl. J Natl Compr Canc Netw. 2019 Aug 1;17(8):896-909. doi: 10.6004/jnccn.2019.0039. J Natl Compr Canc Netw. 2019. PMID: 31390583
Impaired Cytotoxic CD8+ T Cell Response in Elderly COVID-19 Patients.
Westmeier J, Paniskaki K, Karaköse Z, Werner T, Sutter K, Dolff S, Overbeck M, Limmer A, Liu J, Zheng X, Brenner T, Berger MM, Witzke O, Trilling M, Lu M, Yang D, Babel N, Westhoff T, Dittmer U, Zelinskyy G. Westmeier J, et al. Among authors: werner t. mBio. 2020 Sep 18;11(5):e02243-20. doi: 10.1128/mBio.02243-20. mBio. 2020. PMID: 32948688 Free PMC article.
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation.
Gilan O, Rioja I, Knezevic K, Bell MJ, Yeung MM, Harker NR, Lam EYN, Chung CW, Bamborough P, Petretich M, Urh M, Atkinson SJ, Bassil AK, Roberts EJ, Vassiliadis D, Burr ML, Preston AGS, Wellaway C, Werner T, Gray JR, Michon AM, Gobbetti T, Kumar V, Soden PE, Haynes A, Vappiani J, Tough DF, Taylor S, Dawson SJ, Bantscheff M, Lindon M, Drewes G, Demont EH, Daniels DL, Grandi P, Prinjha RK, Dawson MA. Gilan O, et al. Among authors: werner t. Science. 2020 Apr 24;368(6489):387-394. doi: 10.1126/science.aaz8455. Epub 2020 Mar 19. Science. 2020. PMID: 32193360 Free PMC article.
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study.
Swain SM, Ewer MS, Viale G, Delaloge S, Ferrero JM, Verrill M, Colomer R, Vieira C, Werner TL, Douthwaite H, Bradley D, Waldron-Lynch M, Kiermaier A, Eng-Wong J, Dang C; BERENICE Study Group. Swain SM, et al. Among authors: werner tl. Ann Oncol. 2018 Mar 1;29(3):646-653. doi: 10.1093/annonc/mdx773. Ann Oncol. 2018. PMID: 29253081 Free PMC article. Clinical Trial.
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Mirza MR, Åvall Lundqvist E, Birrer MJ, dePont Christensen R, Nyvang GB, Malander S, Anttila M, Werner TL, Lund B, Lindahl G, Hietanen S, Peen U, Dimoula M, Roed H, Ør Knudsen A, Staff S, Krog Vistisen A, Bjørge L, Mäenpää JU; AVANOVA investigators. Mirza MR, et al. Among authors: werner tl. Lancet Oncol. 2019 Oct;20(10):1409-1419. doi: 10.1016/S1470-2045(19)30515-7. Epub 2019 Aug 29. Lancet Oncol. 2019. PMID: 31474354 Clinical Trial.
An update on the role of 18F-FDG-PET/CT in major infectious and inflammatory diseases.
Kung BT, Seraj SM, Zadeh MZ, Rojulpote C, Kothekar E, Ayubcha C, Ng KS, Ng KK, Au-Yong TK, Werner TJ, Zhuang H, Hunt SJ, Hess S, Alavi A. Kung BT, et al. Among authors: werner tj. Am J Nucl Med Mol Imaging. 2019 Dec 15;9(6):255-273. eCollection 2019. Am J Nucl Med Mol Imaging. 2019. PMID: 31976156 Free PMC article. Review.
An update on the role of PET/CT and PET/MRI in ovarian cancer.
Khiewvan B, Torigian DA, Emamzadehfard S, Paydary K, Salavati A, Houshmand S, Werner TJ, Alavi A. Khiewvan B, et al. Among authors: werner tj. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1079-1091. doi: 10.1007/s00259-017-3638-z. Epub 2017 Feb 8. Eur J Nucl Med Mol Imaging. 2017. PMID: 28180966 Review.
702 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page